Antibiotic regimens with rifampicin for treatment of Enterococcus faecium in biofilms

International Journal of Antimicrobial Agents

Volumn 44, Issue 1, 2014, Pages 78-80

  Holmberg, Anna ^a,b   Rasmussen, Magnus ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Biofilm; Enterococcus faecium; Minimum biofilm eradication concentration

Indexed keywords

BONE CEMENT; DAPTOMYCIN; LINEZOLID; RIFAMPICIN; TIGECYCLINE; VANCOMYCIN; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; DRUG COMBINATION; MINOCYCLINE; OXAZOLIDINONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BIOFILM; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; IN VITRO STUDY; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; BACTERIUM ADHERENCE; DRUG COMBINATION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BIOFILMS; BONE CEMENTS; DAPTOMYCIN; DRUG COMBINATIONS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; OXAZOLIDINONES; RIFAMPIN;

EID: 84902544701     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.03.008     Document Type: Article

References (12)

1. C.A. Arias, G.A. Contreras, and B.E. Murray Management of multidrug-resistant enterococcal infections Clin Microbiol Infect 16 2010 555 562
2. C.A. Arias, and B.E. Murray The rise of the Enterococcus: beyond vancomycin resistance Nat Rev Microbiol 10 2012 266 278
3. F.L. Paganelli, R.J. Willems, and H.L. Leavis Optimizing future treatment of enterococcal infections: attacking the biofilm? Trends Microbiol 20 2012 40 49
4. J.A.T. Sandoe, I.R. Witherden, J.H. Cove, J. Heritage, and M.H. Wilcox Correlation between enterococcal biofilm formation in vitro and medical-device-related infection potential in vivo J Med Microbiol 52 2003 547 550
5. J.A.T. Sandoe, J. Wysome, A.P. West, J. Heritage, and M.H. Wilcox Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms J Antimicrob Chemother 57 2006 767 770
6. W. Zimmerli, A.F. Widmer, M. Blatter, R. Frei, and P.E. Ochsner Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group JAMA 279 1998 1537 1541
7. A. Holmberg, M. Mörgelin, and M. Rasmussen Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms J Antimicrob Chemother 67 2012 433 439
8. D. Minardi, O. Cirioni, R. Ghiselli, C. Silvestri, F. Mocchegiani, and E. Gabrielli et al. Efficacy of tigecycline and rifampin alone and in combination against Enterococcus faecalis biofilm infection in a rat model of ureteral stent J Surg Res 176 2012 1 6
9. J.M. Entenza, and P. Moreillon Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies Int J Antimicrob Agents 34 2009 e1 e9
10. K.H. Rand, and H. Houck Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci J Antimicrob Chemother 53 2004 530 532
11. G. Pankey, D. Ashcraft, and N. Patel In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin Antimicrob Agents Chemother 49 2005 5166 5168
12. K.H. Rand, H.J. Houck, and J.A. Silverman Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium J Antimicrob Chemother 59 2007 1017 1020